Pilot or pivotal ? [General Sta­tis­tics]

posted by Ohlbe – France, 2018-06-27 16:13 (2300 d 21:20 ago) – Posting: # 18978
Views: 13,877

Dear ElMaestro,

❝ ❝ OK, maybe if the product has a very low variability and the number of subjects remains very low, it could make sense and save time to directly go for the pivotal. Any experience ?


❝ Yes absolutely. The majority of dossiers are being accepted without pilot trials.


Sure, when you only have one test formulation. But when you hesitate between two ? Would you directly go for a pivotal where both test formulations would be compared to the reference, and then file whichever one passes ?

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
23,252 posts in 4,886 threads, 1,668 registered users;
68 visitors (1 registered, 67 guests [including 7 identified bots]).
Forum time: 13:33 CEST (Europe/Vienna)

If you want a new idea, read an old book.    Ivan Pavlov

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5